Taken together, these data show a specific increase of NR2B subunit and PSD95 that correlates with Aβ42 levels in the prefrontal cortex of brain samples at early stages of AD, which is counteracted along the progression of disease. This evidence concerns the gene GRIN2B and Alzheimer disease.